Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Reported Earlier, Daiichi Sankyo And AstraZeneca Announce First Patient Dosed In DESTINY-Lung06 Phase 3 Trial Of ENHERTU As First-Line Therapy In HER2 Overexpressing Metastatic Non-Squamous NSCLC

Author: Benzinga Newsdesk | October 31, 2025 02:53am

Posted In: AZN DSNKY